This gene is located on chromosome 4, and the CAG expansion in exon 1 produces a mutant huntingtin protein (mHTT) that is abnormally modified posttranslationally, leading to transcriptional, immune, and mitochondrial dysfunction; it also serves as the earliest detectable biomarker in the serum of HD patients [541, 542]. Here, HTT is linked to Huntington disease.